Chen J et al., 2012-08-23: Genetically engineered mouse glioma study: after temozolomide arrests tumour growth, a quiescent nestin-expressing subpopulation with cancer-stem-cell properties regenerates the tumour; ablating those cells arrested growth.
pulse-chase experiments demonstrate a tumour re-growth cell hierarchy originating with the Nes-ΔTK-GFP transgene subpopulation.
p.522 (Abstract)
Chen J et al., 2012-08-23: Genetically engineered mouse glioma study: after temozolomide arrests tumour growth, a quiescent nestin-expressing subpopulation with cancer-stem-cell properties regenerates the tumour; ablating those cells arrested growth. No funding or COI captured in the record. No clinical product; temozolomide was the cytotoxic used in mice. Comparator: TMZ-treated versus untreated and cell-ablated tumours in the same model. This is the closest real Nature paper to the F1 claim, but it reports a cell-population hierarchy and states no percentage at all – nothing in the abstract supports '300 percent'. Study type: animal.
